Breast milk is the reference normative standard for infant feeding. When an infant is diagnosed with chylothorax, provision of breast milk must be temporarily discontinued due to the presence of long chain triglycerides (LCT) that contribute to persistent chylous drainage. In its place, the infant is prescribed a therapeutic formula high in medium chain triglycerides (MCT) as treatment for chylothorax. Families and health care providers are interested in using breast milk, in a modified fat form, as treatment for chylothorax instead. This study will assess growth in infants receiving one of two nutrient enriched modified fat breast milk (MFBM) treatments for chylothorax. If either of the proposed nutrient enrichment methods support growth, MFBM will become a standard chylothorax treatment option for infants at SickKids.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
24
The Hospital for Sick Children
Toronto, Ontario, Canada
Growth - weight
z-score for weight-for-age
Time frame: Throughout chylothorax treatment (average 6 weeks); daily in hospital; weekly as outpatient
Growth - length
z-score for length-for-age
Time frame: Throughout chylothorax treatment (average 6 weeks); calculated daily in hospital; weekly as outpatient
Growth - head circumference
z-score for head circumference-for-age
Time frame: Throughout chylothorax treatment (average 6 weeks); calculated daily in hospital; weekly as outpatient
Feed volume intakes
Time frame: Throughout chylothorax treatment (average 6 weeks); calculated daily in hospital; weekly as outpatient
Energy intakes
Time frame: Throughout chylothorax treatment (average 6 weeks); calculated daily in hospital; weekly as outpatient
Protein intakes
Time frame: Throughout chylothorax treatment (average 6 weeks); calculated daily in hospital; weekly as outpatient
Solid food intakes (type, grams at home measured using a scale (CS2000; Ohaus))
Time frame: Throughout chylothorax treatment (average 6 weeks); daily in hospital; weekly as outpatient
Volume of chest tube drainage
ml/kg/day
Time frame: Throughout chylothorax treatment (average 6 weeks); daily in hospital
Duration of chest tube drainage
measured in post-operative days
Time frame: Throughout chylothorax treatment (average 6 weeks); daily in hospital
Morbidities - hospital re-admission(s)
Time frame: Throughout chylothorax treatment (average 6 weeks)
Morbidities - reaccumulation of chylous fluid
Time frame: Throughout chylothorax treatment (average 6 weeks)
Morbidities - prevalence of serious adverse events
Time frame: Throughout chylothorax treatment (average 6 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.